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Background: Cancer is the second leading cause of death in the United States and 
remains a major public health problem worldwide. Epidemiological studies have 
demonstrated that insulin like growth factor-1 (IGF-1) is linked to ulcers and most 
cancers. Although studies have investigated the role of IGF1 in ulcer healing and cancer 
pathogenesis, the link between ulcer and cancer remains unclear. Hence, we assessed 
the relationship between ulcers and cancers.  
Methods: This study consists of a sample of 180 cancer patients obtain by convenience 
sampling who were seen at Nebraska Medicine and were enrolled in the integrated 
cancer repository for cancer research (iCaRe2) database. Demographics and 
socioeconomic data were described using descriptive statistics and data were analyzed 
using Linear regression and TTEST. 
Results: The result of this study showed no association between ulcer diagnosis and 
age of cancer diagnosis. Although patients with gastroduodenal ulcer seem to be 
diagnosed of cancer later compared to non-gastroduodenal patients, this finding was 
however not significant. 
Discussion: Research on the association between ulcers and cancer is scarce. This 
study is significant in that it will serve as a landmark for future research which may lead 







Cancer is a major public health problem worldwide and it’s the second leading cause of 
death in the United States (Heron, Anderson & Brief, 2016). In the United States, it is 
estimated that about 1,762,450 new cases of cancer and 606,880 deaths would occur in 
2019 (Siegel, Miller & Jemal, 2019).  This study focuses on head and neck, 
gastrointestinal, and pancreatic cancer. Head and neck cancer include neoplasm of the 
oral cavity, pharynx and larynx. Head and neck cancer rank sixth among the most 
common cancers, accounting for approximately 6% of all cancer cases, and more than 
630,000 new cases of head and neck cancer are diagnosed worldwide each year 
(Vigneswaran, Williams, 2014). In the United States, it is estimated that 65,410 people 
(48,000 men and 17,410 women) will develop head and neck cancer in 2019 and 
14,620 would die from it (10,980 men and 3,640 women) (American society of clinical 
oncology, 2019). Although the risk of head and neck cancer is strongly associated with 
smoking and alcohol consumption, epidemiological data has linked elevated levels of 
IGF1 and head and neck cancers (Slomiany et al., 2006)  
Gastrointestinal cancers are cancers involving the digestive tract. These include 
cancer of the esophagus, stomach, colon, rectum and pancreas (Herszenyi, Tulassay, 
2010). The most common sites of GI cancer are the colon and rectum which represent 
over 50% of GI cancers and accounts for the fourth most common cancer type in the 
United States. It is estimated that about 145,600 new cases of colorectal cancer and 
over 51,000 deaths would occur in 2019 (SEER, 2019a) Gastric cancers account for the 
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second most common gastrointestinal cancer and despite its decline in incidence and 
mortality, has remained one of the leading cause of cancer related death worldwide 
(Brenner, Rothenbacher & Arndt, 2009).An estimated 97,915 people currently living with 
gastric cancer in the United States with this cancer account for about 1.8% of all cancer 
death and represent 1.6% of all new cancer cases in the United States. Surveillance 
epidemiology and end results program (SEER), which is an authoritative source for 
cancer statistics in the United States estimated that about 27,510 new cases of stomach 
cancer will occur, resulting in 11,140 deaths (SEER, 2016). The strongest established 
risk factor for gastric cancer is helicobacter pylori infection (Wroblewski, Peek & Wilson, 
2010). Other identified risk factors are smoking, family history of gastric cancer, alcohol 
intake, and dietary factors (Brenner, Rothenbacher & Arndt, 2009). There is a similarity 
in risk factors of gastrointestinal and pancreatic cancers. Pancreatic cancer is a leading 
cause of cancer mortality and remains one of the most fatal neoplasms in the world (Ilic, 
Ilic, 2016). It is the third most common cancer causing death in the USA and the 
seventh leading cause of global cancer death (Karimi et al., 2019) .There are two main 
types of pancreatic cancer: adenocarcinoma that makes up about 85% of cases and 
pancreatic endocrine tumor that accounts for about 5% of cases (Ilic, Ilic, 2016). Based 
on American cancer society estimates, pancreatic cancer would account for 56,770 new 
cases and would cause 45,750 deaths in 2019 (American cancer society, 2019a) 
.Although some risk factors have been shown to be associated with pancreatic cancer, 
the exact cause of pancreatic cancer still remains unknown. Identified risk factors 
include smoking, diabetes, obesity, alcohol consumption, pancreatitis, physical 
inactivity, dietary factors, family history, genetics, increased IGF1 and helicobacter 
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pylori infection (Aier et al., 2019) The prognosis of pancreatic cancer is quite poor with 
an estimated overall 5 year survival rate of 8.2% (Karimi et al., 2019). Despite the  
improved understanding of the epidemiology pancreatic cancer it has remained a major 
public health issue with one of the lowest survival rates.   
 There is epidemiological evidence that insulin like growth factor 1 (IGF1), which is 
known to modulate cell growth and survival, is linked to an increased risk of certain 
cancers, particularly pancreatic, gastrointestinal, and head and neck cancers (Ii et al., 
2011, Barnes et al., 2007, Karczewski et al., 2019). The role of IGF1 in the 
pathogenesis and healing of ulcer is also well known.  Gastric ulceration activates 
expression of several growth factors including IGF-1 which accelerates gastric healing 
by promoting cell re-epithelization, proliferation and cox-2 expression (Nguyen et al., 
2007, Howarth, 2003). More recently evidence has accrued to demonstrate that IGFs 
play an important role in the metastasis and spread of many cancers. The IGF-1 
receptor is commonly over expressed in many cancers including head and neck 
cancers (HNC), as well as gastric and pancreatic cancer. Studies have identified 
pathways emanating from IGF-1 receptor that activates multiple signaling pathways 
which then result in cancer cell proliferation, differentiation, transformation, adhesion, 
and tumorigenicity  (Pollak, 2008, LeRoith, Roberts Jr, 2003). Although several studies 
have investigated the role of IGF in ulcer healing and cancer pathogenesis 
independently, the link between ulcer and cancer remain unclear. This study aims to 
address this gap as well as explore the relationship between ulcer diagnosis and age of 





AIM 1: The main aim of this study is to investigate the relationship between ulcer 
diagnosis and age of head and neck, gastrointestinal and pancreatic cancer diagnosis.  
HYPOTHESIS 
Null hypothesis: There is no difference in the timeline of diagnosis between cancer 
patients with ulcers and cancer patients without ulcers. 
Alternative Hypothesis: Patients with ulcers are diagnosed sooner or later of cancers 
compared to patients without ulcers. 
MATERIALS AND METHODS: 
Data source and study population 
Data from the integrated cancer repository for cancer research (iCaRe2) database was 
used to conduct this study. (iCaRe2) is a multi-institutional bio specimen registry and 
resource created and maintained by the Fred and Pamela Buffet cancer center to 
collect and manage standardized, multi-dimensional, longitudinal data and bio specimen 
on consented adult cancer patient, high risk individuals and normal controls (ICARe2, 
2019). ICaRe2 aims to enable comprehensive study of risk factors of cancer 
development and disease progression as well as enable strategies for prevention, early 
detection and treatment of cancer (ICARe2, 2019). This database is a convenience 
sampling and includes data on quality of life, disease specific parameters, medications, 
treatment, surgical history, survival/outcome, socio-demographics characteristics, health 
behaviors, and anthropometric measures. This case control study consists of a sample 
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of 960 cancer patients who were seen at Nebraska medicine and enrolled in any three 
of the iCaRe2 cancer registry; pancreatic cancer collaborative registry (PCCR), 
gastrointestinal and abdominal collaborative registry (GA CARE), and, head and neck 
cancer registry (HN CARE). ICaRe2 data contains identifiers hence; this study required 
approval from an institutional review board and was approved by UNMC IRB. (IRB # 
204-19-EP) 
Eligibility Criteria 
Eligibility criteria for this study included adult patients above the age of 19, with a life 
time diagnosis of cancer, who enrolled and provided consent in UNMC GACARE, 
PCCR, and HN CARE registry of the iCaRe2 database from January 1 2003 to March 1 
2019 and having a diagnosis of head and neck, gastrointestinal or pancreatic cancer 
and an available survey data. Subjects under the age of 19 were excluded, vulnerable 
subjects including pregnant women, prisoners, decisionally impaired persons and 
educationally disadvantaged individuals were excluded.  Participants who had no data 
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PCCR: Pancreas care registry 
HNCARE: Head and neck care registry 
GACCARE: Gastrointestinal and abdominal care registry 
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A diagnosis of ulcer was based on patient self-report as described in the iCaRe2 core 
data dictionary and questionnaire. Specifically, in iCaRe2, the diagnosis of ulcer was 
based on the following sequential questions:  History of peptic or stomach ulcer? 
Cancer 
Diagnosis of the various cancer type used in this project was based on patient’s medical 
data. Specifically, the diagnosis of patients with gastrointestinal cancer in the 
GACCARE registry was based on upper GI endoscopy and biopsy, laparoscopy, CT, 
and MRI. Diagnosis of pancreatic, and head and neck cancer was by biopsy of the 
tumor. Age at which cancer was diagnosed was also extracted from the patients 
medical data. 
Socio-demographic variables 
Age, sex, race/ethnicity, and income were collected using administered questionnaire 
from iCaRe2 database. Race/ethnicity was reported on the questionnaire as White, 
Black/African American, Asian, American Indian or Alaska native, native Hawaiian/other 
pacific island, and Hispanic or Latino. Income level was categorized in to 7 groups (less 
than $10,000, $10,000-24,999, $25,000-44,999, $45,000-74,999, $75,000-100,000, 






Smoking history and alcohol consumption status were extracted from iCaRe2 
administered questionnaires and was based on the following questions; have you ever 
smoked cigarettes in your life, how many cigarettes did you smoke per day, how many 
years did you smoke in total, cigarette stop age, do you currently drink alcohol, Alcohol 
start age, what was you heaviest use of alcohol?   
Body mass index 
Body mass index (expressed in meter square) was extracted from the medical history. 
According to CDC BMI classification, (<18.50 kg/m2) is underweight, (18.50-24.99 
kg/m2) is considered normal; (25.00-29.99 kg/m2) is classified as overweight, and above 
30 kg/m2 obese (CDC, 2017). 
STATISTICAL ANALYSIS 
Duplicate data were removed and missing data excluded. All three cancer registries 
were merged by case id and 45 controls were randomly selected and merged to 45 
cases bringing the total sample size to 90 patients.  The independent variable was ulcer 
and was treated as a binary variable; the dependent variable was age at cancer 
diagnosis and treated as a continuous variable. Descriptive statistics (percentage, 
frequencies, mean, medians and standard deviation) were used to describe the 
socioeconomic and demographic variables for head and neck, gastrointestinal and 
pancreas cancer. Each patient age of cancer diagnosis was compared with the median 
age of same primary cancer diagnosis of our study population and the U.S population 
after adjusting the age for both sample population. The adjusted mean age of cancer 
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diagnosis for gastroduodenal ulcer patients was then compared to the adjusted mean 
age of cancer diagnosis for patient without gastroduodenal ulcer in both the U.S 
population and iCaRe2 sample using a TTEST. Linear regression was also used to 
analyze the relationship between the adjusted mean age of cancer diagnosis for iCaRe2  
and U.S population. The analysis was conducted with SAS statistical software version 
9.4, (SAS Inc., Cary, NC USA). 
FOUNDATIONAL AND CONCENTRATION COMPETENCY 
EPIMPH2  Apply appropriate study design and data collection methods to answer 
specific epidemiologic questions and address public health issues.Data would be 
requested and collected from iCaRe2, and a case control study would be designed to 
address public health problems of several cancer types 
EPIMPH3 Analyze datasets using computer software. Data collected from UNMC 
iCaRe2 will be analyzed using sas software. 
MPHF21 Perform effectively on interprofessional team. An open channel of 
communication will be maintained with capstone committee members throughout the 














Table 1 Characteristics of study participants by ulcer status, (n=180) 
 
Participant’s characteristics  Gastroduodenal No gastroduodenal Overall  P valuee 
    Ulcer   Ulcer      
 
    No (%).   No (%).   No (%). 
Total    45 (25)   135 (75)  180 (100)  
 
Cancer diagnosis age, years a 65 (13.7)  63 (11.0)  63 (12.4) 
Enrolment age, years a  66 (13.4)  64 (11.1)  65 (12.2)  0.4      
    
Gender     
  Female    20 (44.4)  64 (47.4)  84 (46.7)  
  Male    25 (55.6)  71 (52.6)  96 (53.3)  
 
BMI b 
  Underweight   2 (4.8)   1 (1.1)   3 (2.3) 
  Normal   14 (33.3)  20 (22.5)  34 (26.0)  
  Overweight   15 (35.7)  28 (31.5)  43 (32.8) 
  Obese    11 (26.2)  40 (44.9)  51 (38.9) 
  Missing   3   46   49 
 
Cancer registry 
   GACCARE   11 (24.4)  33(24.4)  44 (24.4) 
   HNCARE   5 (11.1)   15 (11.1)  20 (11.1) 
   PCCR    29 (64.5)  87 (64.5)  116 (64.5) 
 
Smoking c 
  Never Smokers  10 (24.4)  39 (43.3)  49 (37.4) 
  Ever Smokers   31 (75.6)  51 (56.7)  82 (62.6) 
  Missing   4   44   48 
  Refuse d   0   1   1 
 
Alcohol intake d, e 
  < 1 drink/month  12 (27.9)  24 (26.4)  36 (26.9)   
  >1 drink /month   31 (72.1)  67 (73.6)  98 (73.1) 
  Total years of intake e  42.9 (13.4)  42.8 (12.5)  42.9 (13.0) 
  Refuse   1   9   10  
  Missing               1   35   36 
 
Race 
  American Indian  1 (2.2)   1 (0.7)   2 (1.1) 
  Asian    0    3 (2.3)   3 (1.7) 
  African American  3 (6.7)   5 (3.8)   8 (4.5) 
  White    41 (91.1)  124 (93.2)  165 (92.7) 




Participants characteristics  Gastroduodenal No gastroduodenal Overall  P-value  
    Ulcer   Ulcer    
 
    No (%).   No (%).   No (%). 
 
Income 
  < $10,000   3 (19.0)   0   3 (7.0) 
  $10,000 - $24,999  4 (25.0)   4 (14.8)   8 (18.6) 
  $25,000-$44,999  4 (25.0)   7 (25.9)   11 (25.6) 
  $45,000-$74,999  2 (12.5)   5 (18.5)   7 (16.3) 
  $75,000-$100,000  1 (6.25)   4 (14.8)   5 (11.6) 
  $>100,000   2 (12.5)   7 (25.9)   9 (20.9) 
  Refused   1    3   4 
  Missing   28   105   133 
 
Notes. 
a, eAge and total year of alcohol intake was presented as mean ± standard deviation, and other data were expressed as 
frequency (weighted %). 
b body mass index (BMI)  <18.5kg/m2  was defined as underweight, BMI between 18.5 and 24.9kg/m2  considered as normal, 
BMI  between 25 and 29.9kg/m2  as overweight and BMI ≥ 30kg/m2  as obese. 
c smoking status was defined base of on participant who had smoked more than 100 cigarettes. 
d one drink was considered as one shot of liquor, a mixed drink, one glass of wine or one 12 ounce of beer per month during a 
12 month period or more than 20 drinks in a lifetime. 




Table 1 shows the general characteristic of participant in the study by gastroduodenal 
ulcer status. Among the 180 included study participants, 45 participants had 
gastroduodenal ulcer and 135 participants do not have gastroduodenal ulcer. The mean 
enrolment age of cancer patient with gastroduodenal ulcer was 66 years and 64 years 
for participants without gastroduodenal ulcer. Participants without gastroduodenal ulcer 
seem to be more obese (44.9) than participant with gastroduodenal ulcer (26.2). There 
was no difference in the mean total years of alcohol intake by gastroduodenal ulcer 
status. Lastly 92 percent of participants in the study were white and 22.6 percent earned 
less than $25,000 annual income. 
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Table 2 Characteristics of study participants by cancer registry, (n=180) 
 
Participants characteristics  GACCAREe  HNCAREf   PCCRg   
    No (%).   No (%).    No (%). 
Total    44   20    116 
 
Ulcer 
  No    33 (75)   15 (75)    87 (75)   
  Yes    11 (25)   5 (25)    29 (15)   
 
Age, years a   59.9 ± 12.3  60.9 ± 13.9   64.8 ± 10.8 
 
Gender     
  Female    27 (61.4)  5 (25)    52 (45)  
  Male    17 (38.6)  15 (75)    64 (55)  
 
BMI b 
  Underweight   1 (4.2)   1 (6.7)    1 (1.1) 
  Normal   8 (33.3)   8 (53.3)    18 (19.6)  
  Overweight   6 (25.0)   4 (26.7)    33 (35.9) 
  Obese    9 (37.5)   2 (13.3)    40 (43.5) 
  Missing   20   5    24 
 
Smoking c 
  Never Smokers  10 (38.5)  3 (20.0)    36 (39.1) 
  Ever Smokers   14 (61.5)  12 (80.0)   56 (60.9) 
  Missing   30   5    23 
  Refuse   0   0    1  
 
Alcohol intake d, e 
  < 1 drink/month  5 (20.8)   0 (0)    31(32.6)  
  >1 drink /month   19 (79.2)  15 (100)   64 (67.4) 
  Total years of intake  39.77 (12.7)  43.71 (15.4)   44 (11.9) 
  Refuse d   0 (0)   0 (0)    10  
  Missing               25   5    11 
 
Race  
  American Indian  1 (2.3)   0 (0)    1(0.9) 
  Asian    1 (2.3)   0 (0)    2(1.7) 
  African American  4 (9.0)   0 (0)    4 (3.5) 
  White    38 (86.4)  19 (100)   108(93.9) 









Table 2. Continue.  Characteristics of study participants by cancer registry, (n=180) 
 
Participants characteristics  GACCAREe  HNCAREf   PCCRg   
    No (%).   No (%).    No (%). 
Total    44   20    116 
 
Income 
  < $10,000   3 (13.6)   0 (0)    0 (0) 
  $10,000 - $24,999  3 (13.6)   4 (28.6)    1(14.3) 
  $25,000-$44,999  6 (27.3)   4 (28.6)    1 (14.3) 
  $45,000-$74,999  3 (13.6)   2 (14.3)    2 (28.6) 
  $75,000-$100,000  2 (9.1)   2 (14.3)    1 (14.3) 
  $>100,000   5 (22.7)   2 (14.3)    2 (28.6) 
  Refused   1    2 (12.50)   1 (25.00) 
  Missing   21   4    108 
 
Notes. 
e Gaccare gastrointestinal and abdominal cancer care registry 
f Hncare head and neck cancer care registry 
g PCCR pancreas cancer care registry  
 a, eAge and total year of alcohol intake was presented as mean ± standard deviation, and other data were expressed as 
frequency (weighted %). 
b body mass index (BMI)  <18.5kg/m2  was defined as underweight, BMI between 18.5 and 24.9kg/m2  considered as normal, 
BMI  between 25 and 29.9kg/m2  as overweight and BMI ≥ 30kg/m2  as obese. 
c smoking status was defined base of on participant who had smoked more than 100 cigarettes. 
d one drink was considered as one shot of liquor, a mixed drink, one glass of wine or one 12 ounce of beer per month during a 
12 month period or more than 20 drinks in a lifetime. 
 
 
            
 
Table 2 shows the general characteristics of participants in the study by cancer registry. 
Among the 180 included study participants, 44 were from gastrointestinal and 
abdominal cancer collaborative registry, 20 were from head and neck cancer registry 
and 116 participants were from pancreas cancer registry. The mean age diagnosis of 
participants with pancreas cancer (64.8 ± 10.8) was higher than the age diagnosis of 
participants with head and neck cancer (60.9 ± 13.9) and gastrointestinal cancer (59.9 ± 
12.3). Among the patients studied for the various cancer types, patients with pancreas 
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cancer seemed to be more overweight and obese than patients with head and neck and 
gastrointestinal and abdominal cancer.  Relative to participants from gastrointestinal 
and abdominal and pancreas cancer registry, participants with head and neck cancer 
had a higher proportion of males (75.00 %) versus 55 % for pancreas cancer and 39.6 
% for gastrointestinal and abdominal cancer patients. Participants seemed to have at 
least one drink per month and a mean total year of alcohol intake of 44 years for head 
and neck and pancreas cancer and 39.8 years gastrointestinal and abdominal cancer.  
Alcohol intake was higher among patients with head and neck cancer (100 %) and 
gastrointestinal cancers (79.1 %) and lower (67.4 %) for pancreas cancer. This finding 
was similar to the smoking status, where 80% of head and neck cancer patient, 60.9% 
of pancreas cancer patient and 61.5% of patients with gastrointestinal cancer had 
smoke at least hundred cigarettes. 
Lastly, a major proportion of participants in the study were white with Head and neck 
cancer (100%), pancreas cancer (93.9%) and gastrointestinal cancers (86.4%). 
Furthermore, 57.2% of patient diagnosed with head and neck cancer earned less than 








Table 3: Median age at cancer diagnosis based on primary cancer type. 
  





















n            age                      
              median 





              
 
 
n   age            
            median 
 
 
      
PCCRa Pancreas 
Cancer 
70.00 63.83 29 68.15 87 63.67 
GACCAREb Colon Cancer 
Female 
72.00 62.03 6 66.21 15 57.00 
 Colon Cancer 
Male 
68.00 63.00 2 68.00 13 61.77 
 Rectal Cancer 63.00 50.82 2 63.66 4 50.02 
 Gastric 
Cancer 
68.00 54.98 1 40.96 1 69.00 
HNCAREc Lip and Oral 
Cavity Cancer 
69.00 61.11 4 63.89 9 61.11 
 Laryngeal 
Cancer 
65.00 78.52 - - 2 78.52 
 Salivary Gland 
Cancer 
64.00 37.43 1 27.73 1 47.13 
 Oropharyngeal 
Cancer 
63.00 58.66 - - 3 58.66 
        
Total  66.70 64.47 45 51.96 135 63.29 
 
Notes. 
Data for U.S median age of cancer diagnosis for lip and oral cavity, oropharyngeal, laryngeal, gastric, and pancreas are 
from SEER (SEER, 2019b). Data for U.S median age of cancer diagnosis colon, rectal and salivary gland cancer are from 
American cancer society (American cancer society, 2019b) 
a  PCCR pancreas cancer care registry 
b Gaccare gastrointestinal and abdominal cancer care registry 




Table 3 shows the number of cases per primary cancer type, the median age at 
diagnosis of each primary cancer type for gastroduodenal ulcer patients and patients 
without gastroduodenal ulcer in our study population and the United States population. 
There is a distinction in the median age of diagnosis of colon cancer by gender and this 
difference is not seen in other primary cancer types. Pancreas cancer had the highest 
number of cases in our sample (116 cases). Gastric, laryngeal and salivary gland 
cancer shared the least number of cases in our sample population (2 cases). Also the 
median age of diagnosis for colon, oropharyngeal, pancreas, rectal, salivary gland and 




Table 4. Association between gastroduodenal ulcers and age cancer diagnosis. 
 























-5.2 (13.4) -6.8 (11.1) 0.4 
iCaRe2   3.8 (12.4) -0.2 (10.6) 0.2 
 
NOTE: 
1 From 2 sample t-test 
2 Data for reference U.S mean age of cancer diagnosis for lip and oral cavity, oropharyngeal, laryngeal, gastric, and 
pancreas are from SEER (SEER, 2019b). Data for reference U.S mean age of cancer diagnosis for colon, rectal and 




µ (ulcer) =  ∑ (normalize cancer diagnosis age for ulcer patient)  
  Number of ulcer cases 
µ (no ulcer) =  ∑ (normalize cancer diagnosis age for non-ulcer patient)  
  Number of non-ulcer cases 
 
Table 4 shows the association between gastroduodenal ulcers and age cancer 
diagnosis using a 2 sample t test. Patients with no ulcer seemed to have lower mean 
age of cancer diagnosis for both U.S (-6.8) and iCaRe2 (-0.2) compare to patients with 
gastroduodenal ulcer U.S (-5.2) and iCaRe2 (3.8).  
 
Table 5. Model of association between gastroduodenal ulcer and cancers iCaRe2 . 
Variables   Beta  Standard P value    
    Coefficient Error     
Enrollment age  0.9  0.0  <0.0 
Gastroduodenal  1.2  0.7  0.1 
ulcer         
 
Linear regression model: Adjusted Age of cancer diagnosis (iCaRe2 sample) = 
gastroduodenal ulcer (yes/no) + enrollment age.  
The result suggest after adjusting for age of enrollment , the age of cancer diagnosis for 
patients with gastroduodenal ulcer is 1.2 year greater than patients with cancer who do 
not have gastroduodenal ulcer however this is not significant p value (0.1) . 
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Table 6. Model of association between gastroduodenal ulcer and cancers U.S. 
Variables   Beta  Standard P value    
    Coefficient Error     
Enrollment age  0.96  0.02  <0.00 
Gastroduodenal  -0.03  0.49  0.95 
ulcer         
 
Linear regression model: Adjusted Age of cancer diagnosis (U.S sample)= 
gastroduodenal ulcer (yes/no) + enrollment age.  
The result suggest after adjusting for age of enrollment , the age of cancer diagnosis for 
patients with gastroduodenal ulcer is  0.03 year lesser than patients with cancer who do 




Research on the association between ulcers and cancer is scarce. The purpose of this 
study was to analyze the relationship between ulcer and age of cancer diagnosis as well 
as compare the mean age of cancer diagnosis between the ulcer and non-ulcer patients 
in our study population. 
The results of our analysis suggest that there was no association between 
gastroduodenal ulcer diagnosis and age of cancer diagnosis. Our finding differ from 
some previous work (Bao et al., 2010), who provided the most direct evidence for ulcer 
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association with pancreas cancer. The study found that gastric ulcer but not duodenal 
ulcer increases the risk of pancreas cancer and some possible mechanism suggested is 
that the association found might be due to the inflammatory response seen in 
Helicobacter pylori infection and the ulcer healing process.  Chronic inflammation 
generates growth a factor among which is IGF1 which might contribute to the pathology 
of pancreas cancer.  
Findings from our study also differ from a matched case control study (Lin et al., 2015), 
who reported a positive association between peptic ulcer and colorectal cancer 
particularly among patients with helicobacter pylori infection thereby, suggesting the role 
played by insulin growth factor 1 in ulcer healing and cancer pathogenesis. The 
discrepancy between our study (Bao et al., 2010) and (Lin et al., 2015) may be largely 
attributed to the small sample size of our study. Data from a large United State cohort 
consisting of 51,529 health workers was analyzed (Bao et al., 2010) and data from 
60,365 study participants was analyzed  (Lin et al., 2015).  
An unexpected finding of our study was the mean difference in age of cancer diagnosis 
for gastroduodenal ulcer patient was higher (-5.15 years) than that for non-
gastroduodenal ulcer patient (-6.79 years) when age of cancer diagnosis was 
normalized to U.S population. However this difference was not significant (P-Value 
0.42). It was also observed that the mean age of cancer diagnosis for patients with 
gastroduodenal in the iCaRe2 was also higher than the age of cancer diagnosis for 
patient with no gastroduodenal ulcer. This finding was also not significant (p value 0.2). 
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The results from this study might have been different if the study had a large enough 
sample size. 
This study is significant in that it will serve as a landmark for future research which may 
lead to establishing the link between ulcers and cancers and thus, predict and or 
prevent certain cancer types through early detection of gastroduodenal ulcers.  
 
LIMITATIONS 
The study had some limitations. First, the diagnosis of our exposure variable of interest 
was based patient self-report of having ulcer. iCaRe2 questionnaire only had a check 
box for which patients tick yes for presence of ulcer. In the absence of ulcer there was 
no check box hence, we assumed all patients that didn’t tick the check box had no ulcer 
there by introducing selection bias. Furthermore, small sample size due to a small 
number of patients who responded to the exposure question of interest was a limitation 
in this study hence, relationship between covariates and outcome variable was not 
studied because it would further reduce our sample size hence crude analysis was 
done. Also, we were limited in accessing the possibility that occurrence of 
gastroduodenal ulcers preceded the occurrence of cancers because of the limited 
number of patients that reported age of ulcer diagnosis. However the few patients that 
reported age of ulcer diagnosis, data show diagnosis of cancer preceded diagnosis of 
ulcer. Finally, due to unavailability of data, we were limited in exploring the relationship 
between the median age of cancer diagnosis of our sample population and the median 
age of cancer diagnosis among patients seen in Nebraska.  
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The results from this study suggest no association between gastroduodenal ulcer and 
pancreas, head and neck, gastrointestinal and abdominal cancer.  The study was 
limited by sample size hence, further research with a large sample is needed to 
investigate both the association as well as the biologic mechanism that link 
gastroduodenal ulcer and cancers.  
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